Immunophenotypic changes of monocytes in myelodysplastic syndrome and clinical significance
- 2 August 2022
- journal article
- research article
- Published by Springer Nature in Clinical and Experimental Medicine
- Vol. 23 (3) , 787-801
Abstract
Background Myelodysplastic syndrome (MDS) is a type of heterogeneous myeloid clonal disorder usually diagnosed based on a combination of multiple laboratory examinations, including analysis of peripheral blood cells, bone marrow cell morphology and cytogenetics. However, there is a certain difficulty in cases with no distinct changes in hematology and marrow cell morphology. Methods We adopt flow cytometry to quantitatively analyze the immunophenotypic changes of marrow monocytes according to the surface antigens and their combinations at different differentiation stages, so as to study the changes of monocytes during differentiation in patients with bone marrow failure. In the meantime, the relationship between the immunophenotypic changes of marrow monocytes and IPSS-R score and prognosis of MDS patients was analyzed. Results Our results demonstrated disorders of maturation and differentiation of monocytes in patients with MDS and clonal cytopenias of undetermined significance as compared to those with aplastic anemia and healthy individuals. In addition, the differentiation abnormality gradually increased with the disease progression. Furthermore, CD300e expression was found to show significant associations with the clinical stage and disease progression of MDS, and the progression-free survival and AML-free survival were much longer in MDS patients highly expressing CD300e on monocytes. Conclusions CCUS and MDS patients have disorders of differentiation and maturation of monocytes, which tends to be more critical with MDS progression or transforms to AML. Moreover, high CD300e expression has the potential to be a favorable prognostic marker for MDS. This study provides important insights to the role of monocyte immunotyping in the diagnosis, differentiation and prognosis of MDS.Keywords
This publication has 28 references indexed in Scilit:
- The immune landscape of myelodysplastic syndromesCritical Reviews in Oncology/Hematology, 2016
- Antibody to CMRF35-Like Molecule 2, CD300e A Novel Biomarker Detected in Patients with Fulminant Type 1 DiabetesPLOS ONE, 2016
- Diagnostic Utility of Flow Cytometry in Myelodysplastic SyndromesFrontiers in Oncology, 2016
- The 2016 revision to the World Health Organization classification of myeloid neoplasms and acute leukemiaBlood, 2016
- The CD300 molecules: an emerging family of regulators of the immune systemBlood, 2013
- Revised International Prognostic Scoring System for Myelodysplastic SyndromesBlood, 2012
- Immunophenotype of myeloid granulocytes: a pilot study for distinguishing myelodysplastic syndrome and aplastic anemia by flow cytometryInternational Journal of Laboratory Hematology, 2010
- Functional analysis of the CD300e receptor in human monocytes and myeloid dendritic cellsEuropean Journal of Immunology, 2010
- Standardization of flow cytometry in myelodysplastic syndromes: report from the first European LeukemiaNet working conference on flow cytometry in myelodysplastic syndromesHaematologica, 2009
- Monocytes Immunoselected via the Novel Monocyte Specific Molecule, CD300e, Differentiate Into Active Migratory Dendritic CellsJournal of Immunotherapy, 2007